leadership
confidence high
sentiment neutral
materiality 0.50
CNO extends CEO Bhojwani's contract to 2028 and renews poison pill through 2026
CNO Financial Group, Inc.
- CEO Gary C. Bhojwani employment term extended to April 1, 2028 with auto-renewal provisions.
- Fifth Amended Section 382 Rights Agreement extends poison pill to November 13, 2026 to protect NOLs.
- Rights Agreement purchase price set at $110.00 per one-thousandth of Series F Preferred Stock.
- Rights Agreement requires shareholder approval at 2024 annual meeting; otherwise expires Nov 10, 2024.